Interim Dean Stan Gerson, MD
Welcome to the School of Medicine
I am honored to serve you as dean of the school on an interim basis as of July 1, 2020, while maintaining my position as director of the Case Comprehensive Cancer Center. We are fortunate that our future rests on the legacy of leadership and myriad accomplishments of Dean Pamela Davis, advancing medical education and research that will be recognized for decades to come.
Together, our faculty, staff and students in tandem with our exceptional affiliate institutions and facilities comprise a remarkable medical education and research environment. As a destination for medical care, Cleveland is unparalleled and uniquely poised to promote collaborative efforts that are internationally recognized for innovation and quality. All of our physician educators, researchers and physician scientists located across Cleveland—at the School of Medicine, University Hospitals Cleveland Medical Center, the Cleveland Clinic, the MetroHealth System, and the Veterans Affairs Northeast Ohio Healthcare System—are faculty of the school. This offers students a unique learning environment, fostering remarkable collaborations to discover and implement new treatments and prevention strategies. Our basic science, clinical research, health outcomes research, and population and quantitative sciences teams also permeate our school and affiliates.
Our Health Education Campus (HEC), a nearly 610,000-square-foot project with the Cleveland Clinic which opened in the spring of 2019, is the new home for the medical school’s university and Cleveland Clinic Lerner College of Medicine MD programs, as well as the university’s dental and nursing schools. The foundation of our efforts in promoting interprofessional education, the HEC’s signature space is Samson Pavilion, a 477,000-square-foot atrium expressly designed to encourage extensive interaction among all four schools’ faculty, students and staff. Much of our preclinical teaching takes place at HEC with faculty participation from all institutions.
Keeping students, faculty and staff safe during COVID-19, we have adjusted our instruction and education course work to a mix of remote and classroom training and mentoring, adhering to safe practices such as social distancing, mask-wearing and barriers between workspaces. Faculty, research scientists and trainees who were required to remain on campus throughout the pandemic have adapted to restricted working conditions while maintaining remarkable productivity, and many have switched to COVID-19-related research—focusing on high impact science, commercialization and new therapies to benefit patients and community. Our response to the outbreak has been exemplary, applying our skills and new technologies to address this virus and its treatments.
We will continue to build on our long and exceptional history of medical and graduate education, discovery and scholarship across the university while focusing on high impact medical research. And through our affiliated hospital partners and full-time faculty members at those sites, we have established an exceptional and coordinated powerhouse of education, career development, and translational research to better both patients and our community.
I am confident each of you—whether faculty, investigator, educator, staff, trainee or incoming student—will extend your unique contributions so that together, we will continue to create and deliver medical breakthroughs and train the next generation of physicians and scientists, improving healthcare and saving lives here and throughout the world.
I look forward to pursuing our mission together.
Stan Gerson, MD
Interim Dean, School of Medicine and Interim Senior Vice President for Medical Affairs
Director, Case Comprehensive Cancer Center
Director, National Center for Regenerative Medicine
Distinguished University Professor, CWRU
Asa & Patricia Shiverick – Jane B. Shiverick (Tripp) Professor Hematological Oncology
Professor of Medicine, Oncology, CWRU